Loading clinical trials...
Loading clinical trials...
A Phase Ia Trial of ATI-2231 in Advanced Solid Tumor Malignancies
Conditions
Interventions
ATI-2231
Start Date
November 15, 2023
Primary Completion Date
June 30, 2025
Completion Date
June 30, 2025
Last Updated
November 29, 2023
NCT07181681
NCT06257264
NCT07360314
NCT07403721
NCT07539285
NCT07380334
Lead Sponsor
Washington University School of Medicine
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions